接受钙调神经磷酸酶抑制剂联合维多珠单抗治疗的难治性溃疡性结肠炎患者行结肠切除术的危险因素 - Suppr

Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.

作者信息

Fragaki Maria, Demetriou George, Koutroubakis Ioannis E

机构信息

Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece.

Department of Gastroenterology, University Hospital Heraklion, Crete, Greece.

出版信息

Clin Gastroenterol Hepatol. 2019 May;17(6):1213-1214. doi: 10.1016/j.cgh.2018.12.004.

DOI:10.1016/j.cgh.2018.12.004

PMID:31003696

Abstract

摘要

相似文献

Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.

Clin Gastroenterol Hepatol. 2019 May;17(6):1213-1214. doi: 10.1016/j.cgh.2018.12.004.

Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.

Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1236-1244. doi: 10.1080/00365521.2018.1511825. Epub 2018 Oct 24.

Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis.

Aliment Pharmacol Ther. 2020 Aug;52(3):578-579. doi: 10.1111/apt.15896.

Editorial: calcineurin inhibitors as a bridge to vedolizumab for severe ulcerative colitis.

Aliment Pharmacol Ther. 2020 Mar;51(6):663-664. doi: 10.1111/apt.15632.

Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.

Intern Med J. 2014 May;44(5):464-70. doi: 10.1111/imj.12397.

The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.

Aliment Pharmacol Ther. 2014 Sep;40(6):629-38. doi: 10.1111/apt.12873. Epub 2014 Jul 13.

Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.

J Pediatr Gastroenterol Nutr. 2012 Oct;55(4):421-4. doi: 10.1097/MPG.0b013e318252c831.

Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.

Digestion. 2017;95(1):67-71. doi: 10.1159/000452459. Epub 2017 Jan 5.

Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).

Scand J Gastroenterol. 2016;51(2):186-95. doi: 10.3109/00365521.2015.1070900. Epub 2015 Jul 22.

Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study.

Surg Today. 2019 Dec;49(12):1066-1073. doi: 10.1007/s00595-019-01845-2. Epub 2019 Jul 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.

作者信息

机构信息

出版信息

相似文献